A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Abroad (travel likely)Recruiting

Conditions

Follicular Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Weili Zhao, M.D. and Ph.D) · zhao.weili@yahoo.com

Study leads

Weili Zhao
Study Chair
Ruijin Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Non-Hodgkin Lymphoma · Burkitt Lymphoma · Diffuse Large B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Valhalla, United States

Clonal Evolution in Follicular Lymphoma

Follicular Lymphoma

Abroad (travel likely)Recruiting

Bethesda, United States